Med-Logix delivers the most comprehensive ALBA ecosystem for oncological hyperthermia: the ALBA ON 4000D for multi-depth hyperthermia, the ALBA 4D, the world's most advanced phased-array system for deep hyperthermia, dedicated Quality Assurance instrumentation, and PLAN2heat for patient-specific treatment simulation. From planning to delivery to verification, the goal is clear: Boosting the effective radiotherapy dose by up to +20Gy, with the precision radiotherapy demands.
The ALBA devices are in daily clinical use across leading radiation oncology departments and research centers in Europe and Asia, consistently proving the efficacy of hyperthermia to the highest scientific and clinical standards. Ongoing collaborations with top academic institutions keep the ALBA platform at the benchmark for precision, reliability, and treatment quality.
The ALBA network keeps expanding and now reaching North America— a new chapter that brings the full ALBA ecosystem to a broader community of clinicians and researchers worldwide.
With a dedicated team of hardware and software engineers based in Rome's Tiburtino Technology Park, Med-Logix remains committed to advancing hyperthermia technology and expanding access to it globally.
